Letter to Shareholders - Annual Report for the FY 2024-25.
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brooks Laboratories Limited has informed the exchanges that a letter to shareholders along with the Annual Report for the financial year 2024-25 has been dispatched. This is a routine regulatory filing confirming that the annual report has been sent to shareholders. No specific financial figures, guidance, or strategic updates are disclosed in this particular filing. The full Annual Report would contain the detailed financial statements and management discussion.
No direct impact on the stock price; this is a standard procedural compliance filing. Investors should review the full Annual Report for detailed financials, management commentary, and any forward-looking statements.